Zobrazeno 1 - 10
of 21
pro vyhledávání: '"N. N. Tung"'
Publikováno v:
Russian Journal of General Chemistry. 89:1513-1518
Symmetrical fatty dialkyl carbonates make a group of chemicals that has great potential for applications as phase change materials (PCMs). In this study, various parameters affecting synthesis of these carbonates are studied on laboratory scale, whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5487f6264ffc7bd5c1db088aacc720fe
https://doi.org/10.1134/s1070363219070223
https://doi.org/10.1134/s1070363219070223
Autor:
Spring LM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Tolaney SM; Dana-Farber Cancer Institute, Harvard Medical School, Boston., Fell G; Dana-Farber Cancer Institute, Harvard Medical School, Boston., Bossuyt V; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Abelman RO; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Wu B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Maheswaran S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Trippa L; Dana-Farber Cancer Institute, Harvard Medical School, Boston., Comander A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Mulvey T; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., McLaughlin S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Ryan P; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Ryan L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Abraham E; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Rosenstock A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Garrido-Castro AC; Dana-Farber Cancer Institute, Harvard Medical School, Boston., Lynce F; Dana-Farber Cancer Institute, Harvard Medical School, Boston., Moy B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Isakoff SJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston., Tung N; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston., Mittendorf EA; Brigham and Women's Hospital, Harvard Medical School, Boston., Ellisen LW; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston; Ludwig Center, Harvard Medical School, Boston, USA., Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston. Electronic address: Bardia.Aditya@mgh.harvard.edu.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Mar; Vol. 35 (3), pp. 293-301. Date of Electronic Publication: 2023 Dec 12.
Autor:
Mayer EL; Dana-Farber Cancer Institute, Boston, USA. Electronic address: Erica_Mayer@dfci.harvard.edu., Abramson V; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, USA., Jankowitz R; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, USA., Falkson C; University of Rochester Medical Center, Rochester, USA., Marcom PK; Duke University Cancer Institute, Durham, USA., Traina T; Memorial Sloan Kettering Cancer Center, New York, USA., Carey L; University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, USA., Rimawi M; Baylor College of Medicine, Houston, USA., Specht J; Seattle Cancer Care Alliance, Seattle, USA., Miller K; Indiana University Simon Cancer Center, Indianapolis, USA., Stearns V; Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, USA., Tung N; Beth Israel Deaconess Medical Center, Boston, USA., Perou C; University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, USA., Richardson AL; Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, USA., Componeschi K; Dana-Farber Cancer Institute, Boston, USA., Trippa L; Dana-Farber Cancer Institute, Boston, USA., Tan-Wasielewski Z; Dana-Farber Cancer Institute, Boston, USA., Timms K; Myriad Genetics Inc., Salt Lake City, USA., Krop I; Dana-Farber Cancer Institute, Boston, USA., Wolff AC; Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, USA., Winer EP; Dana-Farber Cancer Institute, Boston, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Nov; Vol. 31 (11), pp. 1518-1525. Date of Electronic Publication: 2020 Aug 13.
Autor:
Robson ME; Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York. Electronic address: robsonm@mskcc.org., Tung N; Cancer Risk and Prevention Program, Beth Israel Deaconess Medical Center, Department of Medicine, Dana-Farber Harvard Cancer Center, Boston, USA., Conte P; Division of Oncology, University of Padova, Istituto Oncologico Veneto IRCCS, Padova, Italy., Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Senkus E; Center of Breast Diseases, Medical University of Gdańsk, Gdańsk, Poland., Xu B; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China., Masuda N; Department of Surgery, Osaka National Hospital, National Hospital Organization, Osaka, Japan., Delaloge S; Breast Oncology, Institut Gustave Roussy, Villejuif, France., Li W; Department of Emergency, The First Hospital of Jilin University, Changchun, China., Armstrong A; Medical Oncology, Christie Hospital NHS Foundation Trust, Manchester, UK., Wu W; Global Medicines Development, AstraZeneca, Gaithersburg, USA., Goessl C; Global Medicines Development, AstraZeneca, Gaithersburg, USA., Runswick S; Global Medicines Development, AstraZeneca, Macclesfield, UK., Domchek SM; Department of Medicine, Basser Center, University of Pennsylvania, Philadelphia, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Apr 01; Vol. 30 (4), pp. 558-566.
Autor:
Birkbak NJ; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Li Y; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Pathania S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Greene-Colozzi A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Dreze M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Bowman-Colin C; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Sztupinszki Z; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark., Krzystanek M; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark., Diossy M; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark., Tung N; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA., Ryan PD; Texas Oncology, The Woodlands, USA., Garber JE; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Silver DP; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA., Iglehart JD; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, USA., Wang ZC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, USA., Szuts D; Institute of Enzymolog, Research Center for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary., Szallasi Z; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, USA. Electronic address: Zoltan.szallasi@childrens.harvard.edu., Richardson AL; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, USA. Electronic address: aricha58@jhmi.edu.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Apr 01; Vol. 29 (4), pp. 903-909.
Autor:
Huong VT; Wellcome Trust Major Overseas Programme,Oxford University Clinical Research Unit,Hanoi,Vietnam., Thanh LV; Wellcome Trust Major Overseas Programme,Oxford University Clinical Research Unit,Hanoi,Vietnam., Phu VD; National Hospital for Tropical Diseases,Hanoi,Vietnam., Trinh DT; National Hospital for Tropical Diseases,Hanoi,Vietnam., Inui K; Food and Agriculture Organization,Hanoi,Vietnam., Tung N; Epidemiology Division,Department of Animal Health,Hanoi,Vietnam., Oanh NT; National Centre of Veterinary Diagnosis,Hanoi,Vietnam., Trung NV; National Hospital for Tropical Diseases,Hanoi,Vietnam., Hoa NT; Nuffield Department of Clinical Medicine,University of Oxford,Oxford,UK., Bryant JE; Wellcome Trust Major Overseas Programme,Oxford University Clinical Research Unit,Hanoi,Vietnam., Horby PW; Wellcome Trust Major Overseas Programme,Oxford University Clinical Research Unit,Hanoi,Vietnam., Kinh NV; National Hospital for Tropical Diseases,Hanoi,Vietnam., Wertheim HF; Wellcome Trust Major Overseas Programme,Oxford University Clinical Research Unit,Hanoi,Vietnam.
Publikováno v:
Epidemiology and infection [Epidemiol Infect] 2016 Jan; Vol. 144 (1), pp. 35-44. Date of Electronic Publication: 2015 May 22.
Autor:
Narod SA; Women's College Research Institute, University of Toronto, Toronto, ON., Tung N; Beth Israel Deaconness Hospital, Boston, MA, U.S.A., Lubinski J; Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Huzarski T; Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Robson M; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York City, NY, U.S.A., Lynch HT; Department of Preventive Medicine, Creighton University, Omaha, NE, U.S.A., Neuhausen SL; Beckman Research Institute of the City of Hope, Duarte, CA, U.S.A., Ghadirian P; Epidemiology Research Unit, CHUM-Hôtel-Dieu, Montreal, QC., Kim-Sing C; BC Cancer Agency, Vancouver, BC., Sun P; Women's College Research Institute, University of Toronto, Toronto, ON., Foulkes WD; Departments of Medical Genetics and Oncology, McGill University, Montreal, QC.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2014 Apr; Vol. 21 (2), pp. 64-8.
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study.
Autor:
Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33647, USA., Iqbal J; Familial Breast Cancer Research, Women's College Research Institute, 790 Bay Street, Toronto, Ontario M5G 1N8, Canada., Lynch HT; Department of Preventive Medicine and Public Health, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA., Lubinski J; International Hereditary Cancer Center, Pomeranian Medical University, Al. Powstancow Wlpk. 72, 70-111 Szczecin, Poland., Gronwald J; International Hereditary Cancer Center, Pomeranian Medical University, Al. Powstancow Wlpk. 72, 70-111 Szczecin, Poland., Moller P; Norwegian Radium Hospital N-0310, Oslo, Norway., Ghadirian P; Epidemiology Research Unit, Research Centre of the University of Montreal Hospital Centre (CRCHUM), 3850 Street, Urbain, Montreal, Quebec H2W 1T8, Canada., Foulkes WD; Program in Cancer Genetics, Department of Oncology, McGill University, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada., Armel S; Department of Obstetrics and Gynecology, University of Toronto and Gynecologic Oncology, Princess Margaret Hospital, Toronto, Ontario M5G 2M9, Canada., Eisen A; Sunnybrook Regional Cancer Centre, Toronto, Ontario M4N 3M5, Canada., Neuhausen SL; Department of Population Sciences, Beckmann Research Institute, City of Hope, Duarte, CA 91010, USA., Senter L; Division of Human Genetics, The Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH 43210, USA., Singer CF; Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria., Ainsworth P; London Regional Cancer Program, London, Ontario N6A 4L6, Canada., Kim-Sing C; BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada., Tung N; Beth Israel Deaconess Medical Center, Cancer Risk and Prevention Program, 330 Brookline Avenue, Boston, MA 02215, USA., Llacuachaqui M; Familial Breast Cancer Research, Women's College Research Institute, 790 Bay Street, Toronto, Ontario M5G 1N8, Canada., Chornokur G; Department of Cancer Epidemiology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33647, USA., Ping S; Familial Breast Cancer Research, Women's College Research Institute, 790 Bay Street, Toronto, Ontario M5G 1N8, Canada., Narod SA; Familial Breast Cancer Research, Women's College Research Institute, 790 Bay Street, Toronto, Ontario M5G 1N8, Canada.
Publikováno v:
British journal of cancer [Br J Cancer] 2014 Jan 21; Vol. 110 (2), pp. 530-4. Date of Electronic Publication: 2013 Nov 28.
Autor:
Feller K; Division of Graduate Medical SciencesDepartment of Pathology and Laboratory Medicine, andDermatopathology section, Department of Dermatology, Boston University School of Medicine, Boston, MA, USA., Yang S, Tung N, Lee J, Mahalingam M
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2014 Jan; Vol. 28 (1), pp. 120-4. Date of Electronic Publication: 2012 Aug 07.
Autor:
Iqbal J; Women's College Research Institute, Familial Breast Cancer Research, 790 Bay Street, Toronto, Ontario, Canada M5G 1N8., Ragone A, Lubinski J, Lynch HT, Moller P, Ghadirian P, Foulkes WD, Armel S, Eisen A, Neuhausen SL, Senter L, Singer CF, Ainsworth P, Kim-Sing C, Tung N, Friedman E, Llacuachaqui M, Ping S, Narod SA
Publikováno v:
British journal of cancer [Br J Cancer] 2012 Dec 04; Vol. 107 (12), pp. 2005-9. Date of Electronic Publication: 2012 Oct 25.